亚太地区热性自身免疫血液溶解性贫血症管理:德尔菲小组专家共识和系统文献审查
Phil Choi1, Alberta Hoi2, Rong Fu3
1Caberra Hospital Canberra Australia.
EJHaem
|November 10, 2025
概括
这项研究评估了亚太地区的温暖自身免疫溶血性贫血症 (wAIHA). 它强调需要制定特定区域的治疗指南,提高疾病意识,以提高患者的护理.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 临床研究 临床研究
背景情况:
- 温暖的自身免疫溶血性贫血 (wAIHA) 是一个重大的临床挑战.
- 了解区域治疗差异对于有效的患者管理至关重要.
研究的目的:
- 评估亚太地区 (APAC) wAIHA的负担和治疗做法.
- 制定关于WAIHA诊断和治疗的共识建议.
主要方法:
- 对观察性研究进行了系统的文献审查.
- 一个德尔菲小组召开会议,就诊断,治疗目标和算法达成共识.
- 确定了关键的挑战和研究重点.
主要成果:
- 皮质类固醇是主要的第一线治疗,反应率高 (81%-96%),但复发率显著 (18%-45%).
- 建议对潜在疾病进行常规查和早期干预.
- 限制Rituximab的获取和医生意识上的差距被确定为亚太地区的关键挑战.
结论:
- 在亚太地区,基于证据的,区域适应的wAIHA治疗算法是必不可少的.
- 解决流行病学,结果和生活质量方面的数据缺口对于改善患者护理至关重要.
相关概念视频
Rheumatic Heart Disease III: Medical Management
272
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
272
Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Pericarditis III: Medical Management
294
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
294
Nephrotic Syndrome II : Assessment and Medical Management
187
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
187
Rheumatic Heart Disease IV: Nursing Management
256
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
256
Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K


